| PTX | Paclitaxel |
| C-mab | Cetuximab |
| SCC | Squamous cell carcinoma |
| ADCC | Antibody-dependent cellular cytotoxicity |
| OSCC | Oral squamous cell carcinoma |
| EGFR | Epidermal growth factor receptor |
| OS | Overall survival |
| PFS | Progression-free survival |
| NCCN | National Comprehensive Cancer Network |
| IC50 | 50% inhibitory concentration |
| ANOVA | Analysis of variance |
| PCR | Polymerase chain reaction |
| EGF | Epidermal growth factor |
| KRAS | V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
| HRAS | V-Ha-ras Harvey rat sarcoma viral oncogene homolog |
| BRAF | V-raf murine sarcoma viral oncogene homolog |
| Akt | V-akt murine thymoma viral oncogene homolog |
| PTEN | Phosphatase and tensin homolog |
| CDKN2A | Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) |
| FBXW7 | F-box and WD repeat domain containing 7 |